SMARTERscreen is three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program 

SMARTERscreen is building on the success of its predecessor, SMARTscreen, which was a two-arm cluster randomised controlled trial. The aim was to test the effectiveness of sending an SMS with motivational and instructional videos from general practices to encourage participation in the National Bowel Cancer Screening Program (NBCSP). 

In SMARTscreen, the intervention group showed a 16% higher uptake of the NBCSP kit compared to the control group (39% vs. 23%). 

Both SMARTscreen and SMARTERscreen target younger individuals in the NBCSP, specifically those aged 50-60 years, as they have the lowest participation rates and are more likely to use smartphones regularly.

SMARTERscreen is a three-arm trial, where the SMS intervention with motivational and instructional videos has been modified based on consumer testing by Associate Professor Belinda Goodwin’s Cancer Council Queensland team. The three-arm trial will compare (1) the modified SMS intervention with (2) a SMS-only approach and (3) a control group (where general practitioners conduct screening according to the guidelines of ‘usual care’). 

Currently, SMARTERscreen has made significant progress with the successful recruitment of 63 general practices, 30 in Queensland and 33 in Victoria. This achievement was made possible by the efforts of Tamara Jolley, Anna Wood and, after Tamara left, Sabine Fletcher. 

To facilitate the intervention delivery, the team is collaborating with health technology company, Healthily, which is sending the SMS-only, and the SMS with the weblink to the motivational/instructional material, through their GoShare platform. Healthily is also adapting the intervention scheduling to send messages on weekends when people are more likely to read them. 

To enhance data accuracy and obtain more detailed insights on intervention response based on factors like sex, age, and location, SMARTERscreen is working closely with the National Cancer Screening Register to collect data directly from them. 

The SMARTERscreen protocol paper is now available while the results’ paper for SMARTscreen is currently under review.  

Find publications related to this research here 

Jennifer G McIntosh1,2,3, Jon D Emery1,2, Anna Wood1,2, Patty Chondros2, Belinda C Goodwin3,5, Judy Trevena 2, Carlene Wilson3, Shanton Chang6, Jane Hocking3, Tina Campbell7, Finlay Macrae8, Kristi Milley 1,2,9, Jie-Bin Lew10, Claire Nightingale3, Ian Dixon11, Makala Castelli11, Nicholas Lee11, Lyle Innes7, Tamara Jolley4, Sally Doncovio12, Kate Broun13, Glenn Austin14, Joyce Jiang15, Mark A Jenkins3   

  1. Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
  2. Department of General Practice and Primary Care, University of Melbourne, Melbourne, Australia.
  3. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  4. Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
  5. Centre for Health Research, University of Southern Queensland, Springfield, Australia.
  6. School of Computing and Information Systems, The University of Melbourne, Melbourne, Australia.
  7. Healthily Pty Ltd, Melbourne, Australia.
  8. Colorectal Medicine and Genetics, The Royal Melbourne Hospital and University of Melbourne Dept of Medicine, Melbourne, Australia.
  9. Primary Care Collaborative Cancer Clinical Trials Group (PC4), Australia
  10. The Daffodil Centre, a joint venture between Cancer Council NSW and the University of Sydney, Sydney Australia
  11. Consumer representative.
  12. Victorian Department of Health, Melbourne, Australia.
  13. Cancer Council Victoria, Melbourne, Australia.
  14. Queensland Health, Brisbane, Australia.
  15. Multicultural Centre for Women’s Health, Melbourne, Australia.
To top